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Epaxial myogenesisZic genes encode a conserved family of zinc ﬁnger proteins with essential functions in neural development
and axial skeletal patterning in the vertebrate embryo. Zic proteins also function as Gli co-factors in Hedgehog
signaling. Here, we report that Zic genes have a role in Myf5 regulation for epaxial somite myogenesis in the
mouse embryo. In situ hybridization studies show that Zic1, 2, and 3 transcripts are expressed in Myf5-
expressing epaxial myogenic progenitors in the dorsal medial dermomyotome of newly forming somites, and
immunohistological studies show that Zic2 protein is co-localized with Myf5 and Pax3 in the dorsal medial lip
of the dermomyotome, but is not expressed in the forming myotome. In functional reporter assays, Zic1 and
Zic2, but not Zic3, potentiate the transactivation of Gli-dependentMyf5 epaxial somite-speciﬁc (ES) enhancer
activity in 3T3 cells, and Zic1 activates endogenous Myf5 expression in 10T1/2 cells and in presomitic
mesoderm explants. Zic2 also co-immunoprecipitates with Gli2, indicating that Zic2 forms complexes with
Gli2 to promoteMyf5 expression. Genetic studies show that, although Zic2 and Zic1 are activated normally in
sonic hedgehog−/− mutant embryos, Myf5 expression in newly forming somites is deﬁcient in both sonic
hedgehog−/− and in Zic2kd/kd mutant mouse embryos, providing further evidence that these Zic genes are
upstream regulators of Hedgehog-mediated Myf5 activation. Myf5 activation in newly forming somites is
delayed in Zic2 mutant embryos until the time of Zic1 activation, and both Zic2 and Myf5 require noggin for
their activation.h Institute, 64 Grove Street,
l rights reserved.© 2011 Elsevier Inc. All rights reserved.Introduction
Zic genes encode a conserved family of zinc-ﬁnger proteins that
have essential functions in the developing vertebrate embryo
(Merzdorf, 2007). Zic proteins also interact cooperatively with Gli
proteins (Mizugishi et al., 2001), a structurally related family of zinc
ﬁnger transcription factors and effectors of Hedgehog signaling (Cai
et al., 2008; Cai et al., 2009; Hui et al., 1994; Lewis et al., 2004; Matise
et al., 1998; Sasaki et al., 1999; Wang et al., 2000). Mutations in Zic
genes lead to neural and skeletal defects similar to those observed in
sonic hedgehog (Shh) and Gli mutant mice and humans (Aruga et al.,
1998; Gebbia et al., 1997; Nagai et al., 1997; Nagai et al., 2000; Nakata
et al., 1997; Purandare et al., 2002), and together, Zic2 and Zic3 are
required for proper somite segmentation (Inoue et al., 2007).
Epaxial myogenesis initiates during somite formation in themouse
embryo through activation of themusclemaster regulator,Myf5, in the
dorsal medial dermomyotome (Buckingham and Relaix, 2007). Sonic
hedgehog andWnt signaling have direct roles inMyf5 regulation in the
epaxial somite (Borello et al., 2006; Borycki et al., 1999; Borycki et al.,
2000), through binding of their Gli and Tcf transcription factoreffectors to binding sites in the Myf5 epaxial somite (ES) enhancer
(Borello et al., 2006; Borycki et al., 1999; Gustafsson et al., 2002;
McDermott et al., 2005). Zic genes also are expressed in the epaxial
domain of the dermomyotome whereMyf5 is activated during somite
formation in mouse and chick embryos (Gaston-Massuet et al., 2005;
Inoue et al., 2007; Sun Rhodes and Merzdorf, 2006). Additionally, Zic-
related genes, lame duck and Macho-1, have been identiﬁed as
myogenic regulators in Drosophila and tunicates. These observations
led us to investigate the role of Zic genes in Myf5 regulation and
epaxial myogenesis in the mouse embryo.
Materials and methods
Plasmids, transient transfections and luciferase assays
Full-length Zic1, Zic2 and Zic3 cDNAs (Aruga et al., 1996) were
cloned by RT-PCR ampliﬁcation of RNA from E9.5 mouse embryos, and
clones were sequenced and subcloned into pCS2 or pAG-3 vectors.
Luciferase reporter plasmids were constructed by inserting 483 bp of
the wild-type or mutant Myf5 epaxial somite enhancer (Gustafsson
et al., 2002) into the vector pdelta51, with a delta-crystalline promoter
that alone has low basal activity and is unresponsive to Shh signaling.
NIH3T3 cells were cultured in 12 or 24-well dishes with 10% FBS in
DMEM, and transiently transfected using Fugene 6 (Roche), using 0.2 μg
121H. Pan et al. / Developmental Biology 351 (2011) 120–127of reporter plasmid and 0.1 μg of the appropriate expression plasmid.
Luciferase activitiesof the cellsweremeasured24 hafter transfection, as
previously described (Gustafsson et al., 2002).
Animals
Zic1 and Zic2 mutant mice were generated and maintained as
previously described (Aruga et al., 1998; Nagai et al., 2000). Bent-tail
(Zic3) (Klootwijk et al., 2000) and noggin (McMahon et al., 1998)
mutant mice were purchased from the Jackson Laboratory. Sonic
hedgehog mutant mice (Chiang et al., 1996) were received from Dr.
Chin Chiang.Fig. 1. Zic1, 2, and 3 and Myf5 are co-expressed in epaxial muscle progenitors in somites
embryos stained with DIG-labeled antisense probes for (A) Myf5 (24 somites), (B) Zic1 (22
ﬁrst detected in the paraxial mesoderm immediately posterior to the newest-formed somite
mesoderm or newly formed, posterior somites, but is observed in the 6th somite pair anteri
line onwhole mounts, as shown for (E)Myf5, (F) Zic1, (G) Zic2, and (H) Zic3. (I, K) Immunoﬂu
expression in the dorsal medial lip of the dermamyotome, overlapping with Zic2 protein (K
arrowheads), dorsal medial lip of the dermomyotome; nt, neural tube; dm, dermomyotom
embryo whole mounts.Whole-mount in situ hybridization, immunoprecipitation and
immunocytochemistry
Digoxigenin-labeled RNA probes were synthesized from cDNA
plasmids and digested and transcribed as follows: Myf5 and Pax3:
HindIII and T7; Sim1: EcoRI and T7; MyoD: MluI and T3; Zic1 (1–102
aa): HindIII and T7; Zic2: (1–259 aa) BamHI and SP6; Zic3 (400–466
aa): Sac I and T7. To compare gene expression patterns, wild-type and
mutant embryos were processed in the same reaction tube for in situ
hybridization reactions and embryo staining (Henrique et al., 1995).
Transverse sections (70–80 μm) of whole mount stained embryos
were generated with a Vibratome 1000 and photographed using DICof E9.5 mouse embryos. In situ hybridization gene expression assays of whole mount
somites), (C) Zic2 (25 somites), and (D) Zic3 (24 somites). Zic2 and Zic3 transcripts are
(red bracket) and newly formed somites. Zic1 expression is not detected in the paraxial
or to the paraxial mesoderm. Transverse sections of embryos were made at the lettered
orescence detectedMyf5 (I) in the myotome of tail somites of E9.5 embryos, with weak
). Sections in I and K were counterstained with Hoechst nuclear dye (J, M). DML (red
e; sc, sclerotome. Somite numbers from posterior to anterior are shown in white on
122 H. Pan et al. / Developmental Biology 351 (2011) 120–127optics (Leica). Immunoprecipitation was performed using anti-myc
antibody (9E10, Cell Center, University of Pennsylvania). Immuno-
precipitates were assayed by immunoblotting with anti-Flag M2
monoclonal antibody (Sigma). For immunoﬂuorescent staining, cells
were ﬁxed 24 h after transfection in 2% paraformaldehyde in 0.1 M
sodium phosphate buffer for 20 min at room temperature and
permeabilized with 0.3% Triton X-100 in phosphate-buffered saline
for 3 min. The cells were incubated in 0.1% Tween-20 in phosphate-
buffered saline for 20 min at room temperature and then with
appropriate antibodies.Immunohistology
Embryos were ﬁxed and cryoembedded according to Bajanca et al.
(2004). Double-labeling with anti-Myf5 (Santa Cruz; 1:5000 to
1:50,000) and anti-Zic2 (Inoue et al., 2007; 1:2500) rabbit polyclonals
was performed using Tyramide Signal Ampliﬁcation kit #13 (Molec-
ular Probes) to detect Myf5 according to the manufacturer's protocol,
in conjunction with secondary detection of Zic2 with biotinylated
anti-rabbit IgG and Fluorescein-Avidin D (Vector). For immunostain-
ing with mouse monoclonal antibodies to MyoD (Dako clone 5.8;
1:100) and Pax7 (DSHB supernatant; 1:3), sections were ﬁrst blocked
with MOM block (Vector). Secondary detection was performed with
biotinylated anti-mouse IgG (Vector) and Fluorescein-Avidin D as
above.Fig. 2. Zic1 and Zic2 interact and functionally synergize with Gli1 and Gli2 in Myf5 activati
mutant (GlimutES) Myf5 ES enhancer-luciferase reporters and Gli1 and 2 and Zic1, 2, and 3
reporters with 8X multimers of wild-type (8Xgliwt) or mutant (8Xglimut) Gli binding site
(C) Western blot analysis of 3T3 cell-expressed, ﬂag-tagged Zic2 and/or myc-tagged Gli2 p
antibody 9E10. (D) Immunostaining assays of the nuclear localization of Zic2 and cytoplas
(upper panel), and the nuclear co-localization of Zic2 and Gli2 in 3T3 cultures co-transfected
MyoD in a stable line of Zic1-transfected 10T1/2 cells, as assayed by RT-PCR ampliﬁcation,
embryos, infected with control MSCV and Zic2-expressing MSCV and assayed for Myf5, MySemi-quantitative reverse transcription-PCR (RT-PCR)
Each PCR cycle was 94 °C for 30 s, 57 °C for 30 s, and 72 °C for 1 min.
Zics were ampliﬁed in the presence of 5% DMSO. GAPDHwas ampliﬁed
for 27 cycles and other genes were ampliﬁed for 30–33 cycles. The
primers for PCR ampliﬁcation were as follows: Zic1, 5′-CTCAGGGCTCA-
CAGCCTTC-3′ and 5′-TCCACGATGCTCCTGGACG-3′; Zic2, 5′-GCTGG-
CCATGCTTCTGGAC-3′ and 5′-TCGATCCACTTGCAGATGAG-3′; Zic3,
5′-CGACAAGTCCTACACACC-3′ and 5′-TCCACGATGCTCCTGGACG-3′;
Myf5, 5′-AGCTTGCAAGAGGAAGTCCA-3′ and 5′-TGCTGTCAAAGCTGC-
TGTTC-3′; MyoD, 5′-GCGCTCCAACTGCTCTGA-3′ and 5′-CTGGGTTCC-
CTGTTCTGTGT-3′; GAPDH, 5′-GCAGTGGCAAAGTGGAGATT-3′, and
5′-CTAAGCAGTTGGTGGTGCAG-3′; Gli1, 5′-GAGGTTGGGATGAA-
GAAGCA-3′ and 5′-CAAAAGGGCAGACCAGAAAG-3′; Gli2, 5′-CCCTG-
CACTGGAGAAGAAAG-3′ and 5′-CAGGGTGTGGAGAAAGTCGT-3′;
Gli3, 5′-GGCCTCGCTGATCAAGAA-3′ and 5′-ACGGTGTGGGGAGATCCT-3′.
Relative levels of Myf5 expression were obtained by normalization to
levels of GAPDH expression.Explant cultures, virus construction, and viral infection
Mouse Zic cDNAs encoding the entire open reading frames were
cloned in the viral vectors, pK1 or pLXRN, and production of high titer
virus followed protocols provided by Clontech. Retroviral titers ranged
from 1×108 to 5×108 CFU/ml. E9.5 mouse embryonic tissues wereon. (A) Transactivation assays of 3T3 cells transfected with wild-type (GliwtES) or Gli
expression vectors. (B) Transactivation assays of 3T3 cells transfected with luciferase
sequence from the Myf5 epaxial somite enhancer and Gli2 and Zic2 expression vectors.
rotein extracts before (input) and after (output) immunoprecipitation with anti-Myc
mic localization of Gli2 in 3T3 cells transfected with tagged expression plasmid alone
with tagged Zic2 and Gli2 expression plasmids (lower panel). (E) Expression ofMyf5 and
using GAPDH as an ampliﬁcation control. (F) Paraxial mesoderm explanted from E9.5
oD, GAPDH, Gli1, Gli2, and Gli3 expression using RT-PCR ampliﬁcation.
123H. Pan et al. / Developmental Biology 351 (2011) 120–127isolated and cultured in collagen as explants as previously described
(Borycki et al., 1999). For retroviral infection of tissue explants, 5 μl of
retroviruswas added to 40 μl ofmediumand 10 μg/ml of polybrenewas
also added to increase infection. After overnight incubation, themedium
was replaced by500 μl of freshmedium. The cultureswere incubated for
an additional 3 days and analyzed by RT-PCR.
Stable transfection of 10T1/2 cells
Zics,Myf5, andvector pAG3expressionvectors (5 μgDNAeach)were
transfected into 10T1/2 cells using Fugene6 (Roche). Transfectantswere
monitored cytologically for 12–14 days after selection in 200 μg/ml
Hygromycin. Myogenesis in living cells was scored visually for theFig. 3. Zic2 is required forMyf5 andMyoD activation in epaxial muscle progenitors of newly fo
(A–F) and transverse sections (G, H) of E8.5, E9.0, and E9.5 wild-type embryos (A, C, E) an
embryos (I, K) and Zic2kd/kd mutant embryos (J, L) at E10.5. In Zic2kd/kd mutant embryos, My
somites (yellow arrowheads showmost posterior somite expressing epaxialMyf5 orMyoD in
in hypaxial muscle progenitors of the ventral lateral lip (VLL) of the dermomyotome. Black a
(E, F) and transverse sections of the VLL (G, H). Sim1 expression in the central dermomyotom
compare red andwhite brackets). Pax3 expression in the dermomyotome (O, P, yellow line) i
artifact). Somite numbers from posterior to anterior are shown on embryo whole mounts.presence of multinucleated cells in colonies of about 104 cells, after
treatment with differentiation medium containing 2% serum, followed
by isolation using cloning rings and expansion (Pinney et al., 1988).
Results and discussion
Expression of Zic mRNAs and proteins in newly forming somites
Zic1, Zic2, and Zic3 expression was assayed in developing mouse
embryos using whole mount in situ hybridization assays (Nagai et al.,
1997; Tajbakhsh et al., 1997). Consistentwith earlier reports,weobserved
that Zic2 and Zic3 transcripts are activated in the presomitic mesoderm
(PSM) immediately posterior to the ﬁrst-formed somite (S1) whereMyf5rmed somites. In situ hybridization assays ofMyf5 expression in whole mount embryos
d Zic2kd/kd mutant embryos (B, D, F). MyoD expression was assayed in Zic2 wild-type
f5 and MyoD activation was delayed in the epaxial progenitors in the DML of posterior
A–F, I, J; orange arrowheads mark DML), but the timing ofMyf5 andMyoD is unaffected
rrowheads mark the most posterior somite expressing hypaxialMyf5 in whole mounts
e of wild-type embryos (M, red bracket) is expanded dorsally in Zic2kd/kd embryos (N,
s unaffected in Zic2kd/kdmutant embryos (N.B. The open neural tube in (P) is a sectioning
Black lines on whole mounts show sites of transverse sections.
124 H. Pan et al. / Developmental Biology 351 (2011) 120–127is ﬁrst activated in the dorsal medial lip (DML; Fig. 1A, C and D) in E9.5
mouse embryos (Borycki et al., 1999; Inoue et al., 2007;Nagai et al., 1997).
Their expression persists in the dorsomedial region of the somite, where
epaxial muscle progenitors arise and myotome differentiation initiates
(BuckinghamandVincent, 2009).Zic1activation is detecteddeﬁnitively in
the 6th somite pair (S6) anterior to the newest formed somite and PSM
(Fig. 1B). Zic1 and Zic2 transcripts are also expressed in the dorsal neural
tube and in cells between the neural tube and dermomyotome in more
anterior, mature somites, which are likely migratory neural crest cells
(Fig. 1F, G, K; Inoue et al., 2007; Nagai et al., 1997). Immunohistological
analyses reveal that Zic2 protein is expressed in the dorsal medial region
of the dermomyotome, including theDML,whereMyf5 andPax3proteins
are also expressed (Fig. 1I-L and data not shown). Similar to RNA
expression patterns, Zic2 protein is detected in the dorsal neural tube and
in presumptive neural crest cells migrating between the dermatome and
neural tube (Fig. 1K), but is not co-expressedwithMyoD in thedeveloping
myotome, wheremuscle differentiation initiates (data not shown). These
ﬁndings provide evidence for the co-expression of Zic2 and myogenic
proteins in epaxial muscle progenitors.
Zic1 and Zic2 transactivate the Myf5 ES enhancer and gene in NIH 3T3
and 10T1/2 cells and the presomitic mesoderm
To investigate whether Zic1, Zic2, and Zic3 function in Myf5
regulation, we assayed their ability to transactivate Gli reporters inFig. 4. Genetic interactions of Zic1 and Zic2 inMyf5 regulation. In situ analysis of Zic1 express
wild-type (C, F), Zic1+/+; Zic2+/kd (D, G) and Zic1+/−; Zic2+/kd (E, H) embryos. Zic2+/kd embr
and unpublished data). Yellow arrows mark gene expression in epaxial DML and black arrow
shown in white on embryo whole mounts.3T3 cells, which express Gli2 and Gli3, but not Zic RNAs (Gustafsson
et al., 2002). NIH 3T3 cells were co-transfected with Zic and/or Gli
expression vectors together with the Myf5 epaxial somite (ES)
enhancer luciferase reporter (Gliwt ES), which has a Gli binding site
that is essential for its activity in transactivation assays in 3T3 cells
and for directing localized expression of a β-gal reporter gene in the
epaxial somite in transgenic mouse embryos (Gustafsson et al., 2002).
Transfections were also performed with an ES luciferase reporter
containing a mutant Gli binding site (Glimut ES). These transactiva-
tion studies reveal that Gli1 or Gli2 or Zic1 or Zic2 alone transactivate
the Myf5 ES enhancer luciferase reporter, and that their activities
require a functional Gli binding site (Fig. 2A; Gustafsson et al., 2002).
Importantly, co-transfection of Zic1 or Zic2 with Gli1 or Gli2 further
enhances transactivation by 5–7 fold and also requires a functional Gli
binding site. As Zic proteins have a weak afﬁnity for Gli DNA binding
sites (Mizugishi et al., 2001), the transactivation activity of Zic1 and
Zic2 alone is likely due to interactions of expressed Zic proteins with
endogenously expressed Gli2. Zic3 and Gli3 both failed to activate the
Myf5 ES enhancer reporter (Fig. 2A and data not shown). Zic2 also was
shown to synergize with Gli2 in transactivation assays with an 8X Gli-
luciferase reporter (8XGliwt), which has a multimerized Gli binding
site under control of a thymidine kinase promoter; this synergistic
activity also requires a functional Gli binding site, as indicated by
transfections with a mutant luciferase reporter (8X Glimut). Together,
these data provide evidence that Zic1 and Zic2 have a functional roleion in wild-type (A) and Zic2kd/kd (B) embryos, andMyf5 expression in whole mounts of
yos are slightly smaller than wild-type littermates (Aruga et al., 2002, Inoue et al., 2007,
s mark gene expression in hypaxial VLL. Somite numbers from posterior to anterior are
Fig. 5. Shh is essential forMyf5, but not for Zic2 activation in epaxial somite progenitors.
(A) Myf5 expression is absent in the epaxial DML (orange arrow) of Shh−/− mouse
embryos, but is unaffected in hypaxial VLL (black arrowheads). (B) Zic2 is appropriately
activated in Shh−/− embryos. Black lines show site of transverse sections in C, D. Yellow
arrows mark the most posterior expressing somite. Orange arrows mark the DML.
Somites are numbered from posterior to anterior on embryo whole mounts. nt, neural
tube; sc, sclerotome; dm, dermomyotome.
125H. Pan et al. / Developmental Biology 351 (2011) 120–127in Gli-dependent Myf5 regulation, likely through direct interactions
with Gli1 and Gli2. Consistent with this possibility, we also show that
full-length Zic2 and Gli2 proteins co-immunoprecipitate when
expressed in 3T3 cells, indicating that these proteins are associated
in complexes in vivo (Fig. 2C). Immunolocalization assays also show
that expressed Zic2 enhances the nuclear localization of Gli2 (Fig. 2D),
as previously reported (Koyabu et al., 2001). When Gli2 is expressed
alone, 56% of cells had Gli2 localized in the cytoplasm, 28% in both the
cytoplasm and nucleus, and 16% in the nucleus. By contrast, when Gli2
and Zic2 were co-expressed, 35% of the cells had Gli2 localized to the
cytoplasm, 32% to both the cytoplasm and nucleus, and 33% to the
nucleus, providing further evidence that Zic and Gli proteins
functionally interact and suggesting that Zic2 promotes Gli function
by promoting its nuclear localization.
The effects of Zic1 and Zic2 on endogenous Myf5 gene expression
were investigated in 10T1/2 cells and posterior PSM explants from E9.5
mouse embryos.We found that Zic1 expression in 10T1/2 cells activates
bothMyf5 andMyoD expression (Fig. 2E), as assayed by RT-PCR. Clonal
analysis revealed that only 3% of Zic1-expressing clones expressed the
differentiation marker, myosin heavy chain, based on MF20 immunos-
taining. In contrast, greater than 40% ofMyf5-expressing 10T1/2 clones
expressed MF20, suggesting that Zic1 expression activates Myf5 and
MyoD as part of an upstream myogenic program, but does not support
and/or possibly suppresses myogenic differentiation, which is normally
promoted when Myf5 and MyoD are expressed in cells. We also
expressed Zic2 in surgical explants of the posterior PSM from E9.5
embryos, with similar results. Posterior PSM expresses Gli1, Gli2, and
Gli3 RNAs, but not Zic2, Zic3 or Myf5 RNAs, as assayed by RT-PCR.
However, when PSM was infected with MSCV-Zic2, Myf5 and MyoD
expressionwas detected (Fig. 2F), but notmyogenin orα-actin (data not
shown) further showing that Zic2 promotes expression of upstream
myogenic regulators, but not myogenic differentiation. In the embryo,
MyoD is activated after Myf5 in the epaxial somite, but its timely
activation requires Myf5 (Tajbakhsh et al., 1997), suggesting thatMyoD
expression in PSM explants and 10T1/2 cells is a downstream response
toZic2-mediatedMyf5activation. PSM infectedwithMSCVcontrol virus
or with MSCV-Zic3 did not activate Myf5 or MyoD (data not shown),
providing supporting evidence that Zic3 is not a Myf5 regulator (see
Fig. 2A).
Genetic studies of Zic2 regulation of Myf5 during somite formation
Zic1−/− and Bent Tail (Zic3−/−) mutant embryos activate Myf5
normally during somite formation (data not shown). However, Zic2
knockdown (Zic2kd/kd) embryos, which express b10% the level of Zic2
observed in wild-type embryos (Aruga et al., 2002), are delayed in
epaxial Myf5 activation in the posterior somites at E8.5 and E9.0
(Fig. 3A–D). Myf5 activation in the epaxial domain of the dermomyo-
tome is also delayed at E9.5 until approximately the 10th somite pair
(S10) (n=3) (Fig. 3E–H). At E10.5, MyoD activation is delayed in the
epaxial domain of somites posterior to the forelimb bud (Fig. 3I–L). This
delay in epaxialMyoDmirrors the delayed activation ofMyf5 in Zic2kd/kd
mutant embryos, consistent with the idea that Myf5 is required for
timelyMyoD activation (Kassar-Duchossoy et al., 2004; Tajbakhsh et al.,
1997). Notably, Zic2kd/kd embryos activate Myf5 normally in hypaxial
muscle progenitors localized to the ventral lateral lip (VLL) (Fig. 3F, H),
which is outside the domain of Zic expression and Hedgehog signaling
(Borycki et al., 1999; Kruger et al., 2001). We also observed that
expression of Sim1, a lateral somite and hypaxial marker (Ahmed et al.,
2006), is expandeddorsomedially in E9.5 Zic2kd/kd embryos (Fig. 3M, N),
consistentwith a broader role for Zic2 in somite patterning (Inoue et al.,
2007). Pax3 is expressed throughout the dermomyotome in somites of
bothwild-type and Zicmutant embryos (Fig. 3O, P), indicating that Zic2
does not controlMyf5 andMyoD activation through regulation of Pax3,
or that other Zics expressed in this region are able to functionally
compensate for the loss of Zic2 (Tajbakhsh et al., 1997).As Zic1 and Zic2 are functionally redundant in Myf5 ES enhancer
regulation (Fig. 2), the delayed activation of Myf5 in more mature
somites of Zic2kd/kd embryos (Fig. 3E, F) is likely controlled by Zic1.
Consistent with this hypothesis, Zic1 is activated normally anterior to
the PSM in Zic2kd/kd mutant embryos, with expression ﬁrst clearly
detected in the same somite pair (S6) as the littermate control (n>3
litters, Fig. 4A, B). This observation also indicates that the epaxial
domain is functionally intact in Zic2kd/kd embryos, and that Zic1 and
Zic2 are under independent regulation. Zic1−/−;Zic2kd/kd double
homozygous mutant embryos die during early embryogenesis
(Aruga et al., 2002), but we also observed that Myf5 expression in
Zic1+/−;Zic2+/kd compound mutant embryos is diminished and
delayed in the 6th to 9th most posterior somites of E9.25 embryos
(n=3; Fig. 4C, E), but is unaffected in heterozygous Zic2+/kd (n=5;
Fig. 4D) and Zic1+/− (n=4; data not shown) mutant embryos,
consistent with the conclusion that Zic1 and Zic2 are functionally
redundant for Myf5 regulation.
We observed that Zic1, 2, and 3 are activated normally in the epaxial
somite of Shh−/−mutant embryos, in contrast to Myf5 (Fig. 5 and data
not shown), which requires Shh signaling and Gli transcription factors,
as previously reported (Borello et al., 2006; Borycki et al., 1999;
126 H. Pan et al. / Developmental Biology 351 (2011) 120–127Gustafsson et al., 2002). The patterned expression of Zic genes in the
epaxial somite is therefore regulated independent of Shh signaling. We
then assayed Zic and Myf5 expression in noggin−/− embryos. Noggin
expression, like Zic2, is localized to the epaxial somite domain and does
not require Gli2/Gli3 or Shh signaling (McDermott et al., 2005;
McMahon et al., 1998). However, in noggin−/− embryos, the activation
of both Zic2 andMyf5 is delayed in newly formed somites until the 10th
somite pair anterior to the PSM, when Zic1 also becomes activated
(Fig. 6). Zic2 expression in noggin−/− embryos is unaffected in the
forelimb and signiﬁcantly enhanced in the midbrain and neural tube,
indicating that noggin is selectively required for Zic2 expression in the
epaxial domain of newly forming somites. Theseﬁndings add additional
evidence that Zic2 functions as an upstream activator of Myf5, de-
pendent onnoggin expression. Furthermore, asMyf5 activation requiresFig. 6. Noggin is essential for Zic andMyf5 activation in epaxial somite progenitors. Zic1 expr
somites and overexpressed in the neural tube of noggin−/− embryos.Myf5 expression (E, F)
Zic2 expression in noggin−/− embryos. Yellow arrows mark the most posterior expre
dermomyotome. Somites are numbered from posterior to anterior on embryo whole mou
transcription factors in the activation and patterning of Myf5 for epaxial myogenesis.Shh signaling and Gli2/Gli3 function (McDermott et al., 2005), these
ﬁndings support amodel inwhichGli2/Gli3 function cooperativelywith
Zic1/Zic2 to pattern Myf5 activation in the localized epaxial somite
domain (Fig. 6G). Noggin would thus function as an extracellular
antagonist to block BMP signaling speciﬁcally in the epaxial domain of
its expression (Hirsinger et al., 1997; Marcelle et al., 1997; Reshef et al.,
1998), therebyenabling the localized epaxial expressionof Zic2 and Zic1,
either through blocking BMP repression of Zic gene expression directly,
or through blocking putative Zic activating signals, such as Wnts.
In Drosophila and tunicates, the Zic-related genes, lame duck and
Macho-1, have been identiﬁed as myogenic regulators (Duan et al.,
2001; Nishida and Sawada, 2001; Yagi et al., 2004), indicating that Zic
genes have an evolutionarily conserved function in myogenesis. Our
ﬁndings also point to a cooperative role for Zic genes in Hedgehogession (A, B) is activated normally and Zic2 expression (C, D) is delayed in the posterior
is absent in posterior somites, and has delayed activation in somites anterior to Zic1 and
ssing somite. Orange arrows mark the DML. nt, neural tube; sc, sclerotome; dm,
nts. (G) A model describing the roles of Shh, Wnt and BMP signaling and Gli and Zic
127H. Pan et al. / Developmental Biology 351 (2011) 120–127signaling andGli transcription factor regulation ofMyf5 activation in the
epaxial somite. According to this model, epaxial patterning is deter-
mined by the localized expression of Noggin. The upstream signaling
activators and repressors that pattern Noggin expression in the epaxial
somite domain remain to be deﬁned. The molecular basis for the
speciﬁcity for Zic/Gli interactions with the essential Gli binding site in
the Myf5 ES enhancer is also unknown. Zic proteins expressed in the
dorsal medial somite may interact directly or indirectly with Gli protein
topromote localized activation of theMyf5 ES enhancer activation in the
epaxial somite as well as maintain Myf5-expressing cells in an
undifferentiated state until Zic expression is repressed and myotome
differentiation initiates. Further studies of the regulation of Zic gene
expression and the interactions of Zic and Gli proteins in transcription
complexes with theMyf5 ES enhancer will provide further mechanistic
insight into the role of Zic proteins in epaxial myogenesis.
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